Zobrazeno 1 - 10
of 22
pro vyhledávání: '"A Fayet Pérez"'
Autor:
C Ortí Juan, A Pérez Plasencia, A Fayet Pérez, E Nogué Pujadas, X Larrea Urtaran, Q López Noguera, C Díez Vallejo, M Bruguera Teixidor, A Dordà Benito, R Sacrest Güell
Publikováno v:
Section 4: Clinical pharmacy services.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::8f15afeec666da0662539c9efe2b11fb
https://doi.org/10.1136/ejhpharm-2022-eahp.168
https://doi.org/10.1136/ejhpharm-2022-eahp.168
Autor:
Armengol Alegre, Joan, Baena-Diez, José Miguel, Barceló-Colomer, Maria E., Ciurana-Misol, Ramón, Esteve Lafuente, Eduardo, Fayet Pérez, Anna, Franzi-Siso, Alicia, Garcia-Cerdan, Maria R., Hernández Anguera, Josep M., Marina Clopés Iñaki, Plana Blanco, Toni, Ramos, Rafel, Ribes, Esther, Ríos Rodríguez, Maria A., Salvador-González, Betlem, Santacana Juncosa, Eugènia, Solanas Saura, Pascual, Simonet Aineto, Pere J., Vilaseca Canals, Jordi
Publikováno v:
Scientia
Colesterol; Risc coronari; Hipercolesterolèmia Cholesterol; Coronary risk; Hypercholesterolemia Colesterol; Riesgo coronario; Hipercolesterolemia L’objectiu general d’aquesta guia és disposar d’unes recomanacions basades en l’evidència cie
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______3991::5505d9b010ed9f14baad43044182b703
https://hdl.handle.net/11351/5955.2
https://hdl.handle.net/11351/5955.2
Autor:
Martos-Rosa, Alba, Martínez-de la Plata, Juan Enrique, Morales-Molina, José Antonio, Fayet-Pérez, Anna, Acosta-Robles, Pedro José
Publikováno v:
Farmacia Hospitalaria, Vol 39, Iss 3, Pp 114-117 (2015)
Farmacia Hospitalaria, Volume: 39, Issue: 2, Pages: 114-117, Published: APR 2015
Farmacia Hospitalaria, Volume: 39, Issue: 2, Pages: 114-117, Published: APR 2015
Según la Agencia Europea del Medicamento, un medicamento biosimilar es aquel obtenido por biotecnología que contiene una versión de la sustancia activa del medicamento biológico original (de referencia o innovador), previamente autorizado en el E
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::5afc09fa4a573a7ae0b3b666c7a930d2
https://pubmed.ncbi.nlm.nih.gov/25817091
https://pubmed.ncbi.nlm.nih.gov/25817091
Autor:
D Gónzalez-Vaquero, M Colls-González, A Martos Rosa, J Urda Romacho, JA Morales Molina, Pedro José Acosta-Robles, A Fayet Pérez
Publikováno v:
European Journal of Hospital Pharmacy. 22:A98.2-A98
Background Progressive multifocal leukoencephalopathy (PML) is an opportunistic infection caused by reactivation of the JC polyomavirus (JCV). It is characterised by severe demyelination of the central nervous system, which is invariably fatal. PML m
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::901127248c650b95e52909b1161439c6
https://doi.org/10.1136/ejhpharm-2015-000639.236
https://doi.org/10.1136/ejhpharm-2015-000639.236
Autor:
JM Fernández Martín, D Gonzalez Vaquero, A Martos Rosa, M Gimeno Jordá, JA Morales Molina, J Urda Romacho, A Fayet Pérez
Publikováno v:
European Journal of Hospital Pharmacy. 22:A81.3-A82
Background Rilpivirine/Emtricitabine/Tenofovir (RPV/FTC/TDF) is a single tablet regimen recommended for treatment-naive HIV patients with baseline viral load (VL) 1 Purpose To analyse the usage profile, effectiveness and safety of RPV/FTC/TDF. Materi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::8bf39736b9c70372b318848762d490f3
https://doi.org/10.1136/ejhpharm-2015-000639.195
https://doi.org/10.1136/ejhpharm-2015-000639.195
Autor:
J Urda Romacho, D Gónzalez-Vaquero, MA Castro-Vida, A Martos Rosa, JM Fernandez-Martin, Pedro José Acosta-Robles, JA Morales Molina, A Fayet Pérez
Publikováno v:
European Journal of Hospital Pharmacy. 22:A188.2-A188
Background Botulinum toxin (BT) is a neurotoxin produced by C. botulinum that blocks the release of acetylcholine at peripheral cholinergic nerve endings. Purpose To evaluate the profile of BT use in our hospital, as well as the savings due to the ma
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::bda2ed2909d44c4407d3e349d8a1bf5b
https://doi.org/10.1136/ejhpharm-2015-000639.453
https://doi.org/10.1136/ejhpharm-2015-000639.453
Autor:
Jose Antonio Morales-Molina, Olivia Urquízar-Rodríguez, JE Martínez-de la Plata, A Fayet-Pérez, JM Fernandez-Martin, Alba Martos-Rosa
Publikováno v:
European Journal of Hospital Pharmacy. 21:A197.3-A198
Background Short Bowel Syndrome (SBS) requires comprehensive nutritional control. Today’s personal media available to healthcare systems do not allow daily monitoring of SBS patients. New technologies should be incorporated into Pharmaceutical Care
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::cf2258eeb0e73a9bced5981ace455e00
https://doi.org/10.1136/ejhpharm-2013-000436.482
https://doi.org/10.1136/ejhpharm-2013-000436.482
Autor:
J Urda-Romacho, A Fayet-Pérez, A Martos-Rosa, O Urquizar-Rodriguez, MA Castro-Vida, JM Fernandez-Martin
Publikováno v:
European Journal of Hospital Pharmacy. 21:A82.3-A83
Background Omalizumab is indicated as add-on treatment to improve asthma control in patients with severe persistent allergic asthma who have reduced lung function as well as frequent symptoms. Purpose To assess the use and efficacy of omalizumab in a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::bbcfff8d740bb7bb903dcb64560829a4
https://doi.org/10.1136/ejhpharm-2013-000436.203
https://doi.org/10.1136/ejhpharm-2013-000436.203
Autor:
Martos-Rosa, Alba, la Plata, Juan Enrique Martínez-de, Morales-Molina, José Antonio, Fayet-Pérez, Anna, Acosta-Robles, Pedro José
Publikováno v:
Farmacia Hospitalaria; March-April 2015, Vol. 39 Issue: 2 p114-117, 4p
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.